Delivery Order SPE2DB24D6044-SPE2DB25FLJBY

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The order is for 4,562,001,996 units of 5 mg dextroamphetamine-amphetamine tablets, with a ceiling value of $3,161.46. The contract is a Firm Fixed Price delivery order, with an ultimate completion date of August 25, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5mg dextroamphetamine tablets. The $1,196.65 firm fixed price contract has a performance period through May 2025 and is not set aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, enabling the company to provide a wide range of pharmaceutical and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,543,073 dextroamphetamine 5 mg tablets in lots of 100. The contract has a ceiling value of $1,937.12 and is a firm fixed price delivery order. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,452.84 firm-fixed-price contract is for the delivery of 4,568,513,835 units of the drug Dextroamphetamine 5 mg Tablets, with a period of performance through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,143.66, is for the delivery of 4,567,018,305 units of dextroamphetamine 5mg tablets. The contract has a firm fixed price and an ultimate completion date of January 24, 2025. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $1,053.12 firm fixed-price delivery order is for 4,567,171,425 units of dextroamphetamine-amphetamine 5 mg tablets. The contract has an ultimate completion date of February 6, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,026.75, is for the delivery of 4,567,426,586 units of 20 mg dextroamphetamine-amphetamine tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 3, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,112.10, is for the delivery of 4,567,944,705 units of Dextroamphetamine 5 mg/5 ml 473 ml. It is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) Troop Support Medical with a delivery order for 4,565,652,514 units of dextroamphetamine solution. The $1,612.71 firm-fixed-price contract has a completion date of September 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to deliver a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,525.60 firm fixed-price delivery order is for the supply of 4,566,601,642 units of dextroamphetamine 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLJBY
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,500 units of 5 mg dextroamphetamine tablets. The $1,937.12 contract has a completion date of June 11, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This award positions AmerisourceBergen as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems with a wide range of pharmaceutical products.

Generated 9/9/25, 12:59 PM